BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17095716)

  • 41. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
    Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
    Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo TRPC functions in the cardiopulmonary vasculature.
    Dietrich A; Kalwa H; Fuchs B; Grimminger F; Weissmann N; Gudermann T
    Cell Calcium; 2007 Aug; 42(2):233-44. PubMed ID: 17433435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/pathological roles.
    Kawabata A; Kawao N
    J Pharmacol Sci; 2005 Jan; 97(1):20-4. PubMed ID: 15655298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteinase-activated receptors (PARs) in infection and inflammation in the gut.
    Vergnolle N
    Int J Biochem Cell Biol; 2008; 40(6-7):1219-27. PubMed ID: 18313348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular mechanisms underlying the cardiovascular actions of oestrogens.
    Ling S; Komesaroff P; Sudhir K
    Clin Sci (Lond); 2006 Aug; 111(2):107-18. PubMed ID: 16831130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall.
    Rao RM; Yang L; Garcia-Cardena G; Luscinskas FW
    Circ Res; 2007 Aug; 101(3):234-47. PubMed ID: 17673684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphingosine 1-phosphate inhibits nitric oxide production induced by interleukin-1beta in rat vascular smooth muscle cells.
    Machida T; Hamaya Y; Izumi S; Hamaya Y; Iizuka K; Igarashi Y; Minami M; Levi R; Hirafuji M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):200-9. PubMed ID: 18171908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protease-activated receptors: novel PARtners in innate immunity.
    Shpacovitch V; Feld M; Bunnett NW; Steinhoff M
    Trends Immunol; 2007 Dec; 28(12):541-50. PubMed ID: 17977790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coagulation and fibrosis in chronic liver disease.
    Calvaruso V; Maimone S; Gatt A; Tuddenham E; Thursz M; Pinzani M; Burroughs AK
    Gut; 2008 Dec; 57(12):1722-7. PubMed ID: 19022928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cadherins, RhoA, and Rac1 are differentially required for stretch-mediated proliferation in endothelial versus smooth muscle cells.
    Liu WF; Nelson CM; Tan JL; Chen CS
    Circ Res; 2007 Aug; 101(5):e44-52. PubMed ID: 17712140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation.
    Russell FA; McDougall JJ
    Inflamm Res; 2009 Mar; 58(3):119-26. PubMed ID: 19184346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiology and pathophysiology of proteinase-activated receptors (PARs): regulation of the expression of PARs.
    Hirano K; Yufu T; Hirano M; Nishimura J; Kanaide H
    J Pharmacol Sci; 2005 Jan; 97(1):31-7. PubMed ID: 15655296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin receptor-mediated vasodilatation: effects of organ culture.
    Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
    Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
    Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
    Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
    Arora P; Ricks TK; Trejo J
    J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How We Learned to Say NO.
    Vanhoutte PM
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1156-60. PubMed ID: 19605779
    [No Abstract]   [Full Text] [Related]  

  • 60. Proteinase-activated receptor pharmacology: trickier and trickier.
    Moffatt JD
    Br J Pharmacol; 2004 Oct; 143(4):441. PubMed ID: 15381632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.